Analytical Method Development and Validation for the Estimation of Imatinib Mesylate and Its Dimer Impurity in Pharmaceutical Formulation by Reverse-Phase High-Performance Liquid Chromatography
Asian Journal of Pharmaceutical and Clinical Research - India
doi 10.22159/ajpcr.2018.v11i3.21073
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2018
Authors
Publisher
Innovare Academic Sciences Pvt Ltd